Evidence map›Paper›PMID 33091800›Full record

ReviewCritical reviews in oncology/hematology2020

The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review.

Gustavo Nader Marta, Charlotte Coles, Orit Kaidar-Person, Icro Meattini, Tarek Hijal, Yvonne Zissiadis, Jean-Philippe Pignol, Duvern Ramiah, Alice Y Ho, Skye Hung-Chun Cheng and 3 more

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Critical reviews in oncology/hematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 26 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05850637 phase2completednot on this map

Phase II Study to Evaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for the Treatment of Early and Locally Advanced Breast Cancer

TypeinterventionalSponsorPrevent Senior InstituteRan2019 to 2023Enrolled60ConditionsBreast Cancer FemaleArmsadjuvant ultra-hypofractionated radiotherapy
NCT07020780 narecruitingnot on this mapstarted 2025, after this paper: background citation

Five Fractions Ultrahypofractionated Whole Breast Radiotherapy and Simultaneous Integrated Boost to the Tumor Bed, for Breast Cancer Patients With Unfavorable Characteristics

TypeinterventionalSponsorIRCCS San RaffaeleRan2025 to 2035Enrolled458ConditionsBreast CancerArmsAdjuvant 5 fractions whole breast irradiation with simultaneous integrated boost to the tumor bed
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. A critical review of randomized controlled trials on topical corticosteroids for the prevention of radiation dermatitis in breast cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Topical non-steroidal agents for the prevention of radiation dermatitis: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Pooled it
  6. The effect of antiperspirant and deodorant use on acute radiation dermatitis in breast cancer patients during radiotherapy: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Pooled it
  7. Article
  8. Article
  9. Article
  10. The smoothing factor in breast intensity-modulated radiotherapy: dosimetric impact and a predictive model of plan acceptability.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Hypofractionated whole and partial breast irradiation: Brazilian Society of Radiotherapy (SBRT) consensus.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Review
  15. Review
  16. Deep inspiration breath hold: dosimetric benefits to decrease cardiac dose during postoperative radiation therapy for breast cancer patients.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2023
    Article
  17. Moderately hypofractionated post-operative radiation therapy for breast cancer: preferences amongst radiation oncologists from countries in Latin America and the Caribbean.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Gustavo Nader MartaDepartment of Radiation Oncology - Hospital Sírio-Libanês, São Paulo, Brazil; Department of Radiology and Oncology - Division of Radiation Oncology, Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. Electronic address: gustavo.marta@hc.fm.usp.br.
Charlotte ColesDepartment of Oncology, University of Cambridge, Cambridge, UK. Electronic address: colesc@doctors.org.uk.
Orit Kaidar-PersonBreast Cancer Radiation Unit, Radiation Oncology Institute, Sheba Medical Center, Ramat Gan, Israel. Electronic address: Orit.KaidarPerson@Sheba.health.gov.il.
Icro MeattiniRadiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy; Department of Experimental and Clinical Biomedical Sciences "M. Serio", University of Florence, Florence, Italy. Electronic address: icro.meattini@unifi.it.
Tarek HijalDivision of Radiation Oncology, McGill University Health Centre, Montréal, Quebec, Canada. Electronic address: tarek.hijal@muhc.mcgill.ca.
Yvonne ZissiadisDepartment of Radiation Oncology, Genesis Cancer Care, Wembley, Western Australia, Australia. Electronic address: Yvonne.Zissiadis@genesiscancercare.com.au.
Jean-Philippe PignolDepartment of Radiation Oncology, Dalhousie University, Halifax, Canada. Electronic address: jean-philippe.pignol@dal.ca.
Duvern RamiahDepartment of Radiation Oncology, Donald Gordon Medical Centre, Johannesburg, South Africa. Electronic address: dr@roncology.com.
Alice Y HoDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA. Electronic address: Alice.Ho@mgh.harvard.edu.
Skye Hung-Chun ChengDepartment of Radiation Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan. Electronic address: Skye@kfsyscc.org.
Gemma SanchoDepartment of Radiation Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Electronic address: gsancho@santpau.cat.
Birgitte Vrou OffersenDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: birgoffe@rm.dk.
Philip PoortmansDepartment of Radiation Oncology, Iridium Kankernetwerk, Wilrijk-Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Wilrijk-Antwerp, Belgium. Electronic address: philip.poortmans@telenet.be.

Funding

Department of Health NIHR300024
6 · The paper itself

Abstract

Post-operative radiation therapy (RT) reduces loco-regional recurrence rates and mortality in most patients with non-metastatic breast cancer. The aim of this critical review is to provide an overview of the applicability of moderately hypofractionated RT for breast cancer patients, focusing on factors influencing clinical decision-making. An international group of radiation oncologists agreed to assess, integrate, and interpret the existing evidence into a practical report to guide clinicians in their daily management of breast cancer patients. We conclude that moderately hypofractionated RT to the breast, chest wall (with/without breast reconstruction), and regional lymph nodes is at least as safe and effective as conventionally fractionated regimens and could be considered as the treatment option for the vast majority of the patients.For those who are still concerned about its generalised application, we recommend participating in ongoing trials comparing moderately hypofractionated RT to conventionally fractionated RT for breast cancer patients in some clinical circumstances.

Indexed as

Breast NeoplasmsBreastHumansNeoplasm Recurrence, LocalRadiation Dose HypofractionationRadiotherapy, AdjuvantBreast cancerRadiation dose hypofractionationRadiation therapyTreatment

Identifiers

PMID33091800
PMCPMC7448956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.